Related Experiment Video
Updated: Jun 27, 2026

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
Published on: June 24, 2025
Biofilm Formation, Virulence-Associated Genes, and Antimicrobial Resistance in Proteus mirabilis Isolates from
Mehdi Choori1, Fateh Rahimi1, Ali Qasemi2
1Department of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan 81746-73441, Iran.
Abstract:
Proteus mirabilis is a frequent cause of complicated urinary tract infections (UTIs), in which biofilm formation and antimicrobial resistance contribute to persistence and therapeutic failure. This study investigated the biofilm-forming capacity, antimicrobial resistance profiles, virulence-associated genes, and genetic diversity of P. mirabilis isolates recovered from UTI patients in Isfahan, Iran. A total of 104 non-duplicate clinical isolates were analyzed. Biofilm formation was quantified using a microtiter plate crystal violet assay, and antimicrobial susceptibility testing was performed according to CLSI guidelines. Extended-spectrum β-lactamase (ESBL) production and extended-spectrum cephalosporin resistance (ESCR) were assessed phenotypically and by PCR. Selected virulence- and biofilm-associated genes were detected by PCR, and clonal relatedness was evaluated using ERIC-PCR. Most isolates were capable of biofilm formation, with 51% classified as strong and 45.2% as moderate producers. High carriage rates of virulence- and biofilm-associated genes, including zapA, zapD, ureC, ureR, luxS, rsbA, and acrA, were observed. ESBL production and ESCR phenotypes were detected in 6.7% and 12.5% of isolates, respectively, while multidrug resistance was observed in 30.4% of isolates. ERIC-PCR analysis identified predominant clonal clusters among isolates exhibiting strong biofilm production. These findings highlight the coexistence of biofilm formation, virulence determinants, antimicrobial resistance, and clonal diversity in uropathogenic P. mirabilis in this region.
Insights
Proteus mirabilis causes complicated urinary tract infections (UTIs). This study found most UTI-causing P. mirabilis isolates form biofilms and carry virulence genes, alongside significant antimicrobial resistance and clonal diversity.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Proteus mirabilis is a significant cause of complicated urinary tract infections (UTIs).
- Biofilm formation and antimicrobial resistance in P. mirabilis contribute to persistent infections and treatment failures.
- Understanding the genetic and phenotypic characteristics of P. mirabilis is crucial for managing UTIs.
Purpose of the Study:
- To investigate the biofilm-forming capacity of P. mirabilis clinical isolates.
- To determine the antimicrobial resistance profiles and identify virulence-associated genes.
- To evaluate the genetic diversity and clonal relatedness of P. mirabilis isolates from UTI patients.
Main Methods:
- Analysis of 104 non-duplicate clinical P. mirabilis isolates from UTI patients.
- Quantification of biofilm formation using microtiter plate assays.
- Antimicrobial susceptibility testing, ESBL/ESCR detection, and PCR for virulence genes.
- Genetic diversity assessed using ERIC-PCR.
Main Results:
- The majority of P. mirabilis isolates exhibited strong (51%) or moderate (45.2%) biofilm formation.
- High prevalence of virulence and biofilm-associated genes (e.g., zapA, ureC, luxS) was observed.
- Significant multidrug resistance (30.4%) and notable rates of ESBL (6.7%) and ESCR (12.5%) were detected.
- ERIC-PCR revealed predominant clonal clusters, particularly among strong biofilm producers.
Conclusions:
- Uropathogenic P. mirabilis isolates frequently possess strong biofilm-forming capabilities and virulence factors.
- Coexistence of biofilm formation, virulence determinants, and antimicrobial resistance is common in P. mirabilis.
- Genetic diversity and clonal expansion contribute to the persistence of P. mirabilis in UTIs.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Biofilms
Microbiota of the Urogenital Tract
Mechanism of Antibiotic Resistance in MRSA
Urinary Tract Infection II: Pathophysiology
Clinical Significance of Antibiotic Resistance

